Chesson Laboratory Associates Inc. (Chesson Labs) is a medical device company which was founded as a Delaware corporation in2006. The Company is based in Durham, North Carolina. The mission of Chesson Labs is “To improve global healthcare by becoming a market leader in the development and delivery of innovative polymer-based medical products”. Chesson Labs has the exclusive worldwide rights to all medical applications of a patented polymer formulation. All of Chesson Labs products cleared for market and in development are based on this patented and patent-pending polymer formulation.

The Company’s Liquid Bandage product received 510(k) market clearance from the United States Food and Drug Administration (FDA) in 2009. The Company is also sponsoring a ca clinical trial for a topical onychomycosis (tyoenail fungus) treatment which it intends to submit to the FDA for potential market clearance in 2010. The Company also has additional products in early stages of development which it anticipates playing significant roles in their respective markets.